In that study, the global metabolite profile of the human ovarian cancer cell line SKOV-3 treated with the non-selective KIAA1363-inhibitor AS115 was compared with those of control cells and a reduction of the MAGE bearing C16:0 alkyl chain was observed. This evidence concerns the gene NCEH1 and ovarian carcinoma.